Epic Corporation Stock Other OTC
Equities
US29428L2051
Blockchain & Cryptocurrency
End-of-day quote
Other stock markets
|
||
- USD | - |
2022 | Sanofi profit gain beats market view on bestseller drug Dupixent | RE |
2022 | Sanofi to float drug ingredients manufacturing business on May 6 | RE |
Sales 2008 | 22.12K 30.1K | Sales 2009 | 5.22K 7.1K | Capitalization | 563K 766K |
---|---|---|---|---|---|
Net income 2008 | - 0 | Net income 2009 | - 0 | EV / Sales 2008 | 33.3 x |
Net Debt 2008 | 399K 544K | Net Debt 2009 | 673K 916K | EV / Sales 2009 | 237 x |
P/E ratio 2008 |
-0.98
x | P/E ratio 2009 |
-1.34
x | Employees | - |
Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Ronald S. Tucker
CEO | Chief Executive Officer | 84 | 97-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald S. Tucker
CEO | Chief Executive Officer | 84 | 97-09-30 |
1st Jan change | Capi. | |
---|---|---|
+19.37% | 50.98B | |
+19.34% | 7.2B | |
-15.80% | 849M | |
+106.67% | 643M | |
-43.67% | 550M | |
+215.09% | 517M | |
-52.94% | 328M | |
-.--% | 118M | |
-16.95% | 118M |